Cure My Disease

Don't miss your cure!

 Log in / Sign up

Free digital tool could speed up chronic pain care in underserved areas

NCT ID NCT07696676

Diagnosis Sponsor: Universidad Central de Venezuela Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests a free, mobile-friendly digital tool designed to help healthcare providers quickly determine the right level of care for people with chronic pain. The tool uses five standard questionnaires to generate a recommendation—from primary care to specialist referral. Researchers will compare the tool's suggestions with decisions made by a panel of pain specialists to see how accurate it is. The goal is to provide a low-cost way to improve pain management in places with limited resources.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PREDICT-DOLOR VE (rule-based clinical decision support tool)
What this could lead to
If accurate, this free digital tool could help doctors in low-resource areas quickly and consistently match chronic pain patients to the right specialist or care level, reducing delays and improving outcomes.
What could go wrong
This is a relatively small study (120 participants) testing diagnostic accuracy, not treatment effectiveness. The tool may not perform as well in other settings or populations, and it relies on patient-reported data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with chronic pain of any etiology (duration of 3 months or longer) presenting at primary care, specialty, or referral centers in Venezuela, recruited consecutively across three participating sites: Hospital Universitario de Caracas, and two regional referral centers in Maracaibo and Valencia or Barquisimeto.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria: * Age 18 years or older * Chronic pain of any etiology with duration of 3 months or longer * Ability to complete the PREDICT-DOLOR VE digital assessment battery (with assistance if needed) * Attending one of the three participating referral centers during the recruitment period * Provision of written informed consent before any study procedure Exclusion Criteria: * Acute pain with duration less than 3 months * Active oncological pain under chemotherapy or radiotherapy protocol (separate evaluation pathway required) * Cognitive impairment that prevents completion of self-report instruments, even with assistance * Active psychiatric emergency or suicidal ideation at time of assessment * Refusal to provide informed consent * Participation in another clinical trial that could influence triage outcomes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Neuropathic pain Pain management

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.